Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.21.2
Condensed Consolidated Statement of Cash Flows
 6 Months Ended
Jun. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (2,619,449)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (25,092)
Change in fair value of the Warrant Liabilities 1,725,151
Changes in operating assets and liabilities:  
Prepaid expenses and other current asset (628,181)
Due from Sponsor (395,000)
Accounts payable and accrued expenses 111,259
Net cash used in operating activities (1,831,312)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (253,000,000)
Net cash used in investing activities (253,000,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of underwriting discounts paid 248,239,770
Proceeds from sale of Private Placement Warrants 7,060,000
Proceeds from promissory note – related party 70,000
Repayment of promissory note - related party (75,000)
Payment of offering costs (173,750)
Net cash provided by financing activities 255,121,020
Net Change in Cash and cash equivalents 289,708
Cash and cash equivalents – Beginning
Cash and cash equivalents– Ending 289,708
Non-Cash Investing and Financing Activities:  
Offering costs included in accrued offering costs 431,700
Initial classification of Class A ordinary share subject to possible redemption 240,641,840
Change in value of Class A ordinary share subject to possible redemption (32,384,748)
Deferred underwriting fee payable $ 8,855,000